Literature DB >> 12642628

Human kallikrein 13 expression in normal tissues: an immunohistochemical study.

Constantina D Petraki1, Vassiliki N Karavana, Eleftherios P Diamandis.   

Abstract

The human tissue kallikrein 13 gene (KLK13), encoding for hK13 protein, was recently cloned and characterized. Here we describe the immunohistochemical (IHC) localization of hK13 in normal human tissues and compare it with the expression of two other kallikreins, hK6 and hK10. We performed the streptavidin-biotin IHC method on 204 paraffin blocks from archival, current, and autopsy material prepared from almost every normal human tissue, using a polyclonal and a monoclonal hK13 antibody. The staining was cytoplasmic and both antibodies yielded similar results. The hK13 protein was revealed in a variety of tissues, mainly in glandular epithelia. Other epithelia that expressed hK13 included the urothelium, the spermatic epithelium, and the epithelium of the choroid plexus. hK13 was intensely immunoexpressed by some endocrine organs, such as the adenohypophysis, the thyroid gland, the parathyroid glands, the adrenal medulla, the Leydig cells of the testis, and the cells of the endocrine pancreas. Immunoreactivity was also observed in the primordial follicles, the corpus luteum, and sparse luteinized cells in the stroma of the ovary, the trophoblastic cells of the placenta, the Hassall's corpuscles of the thymus, and chondrocytes. Nerves and ganglia of the peripheral nervous system, and both neurons and glial cells in the central nervous system, were positive. In short, hK13 was expressed by many glandular epithelia, some endocrine organs, and some specialized epithelia and cells. Comparison of these data with hK6 and hK10 expression suggests that the three kallikreins have a similar IHC pattern in normal human tissues.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12642628     DOI: 10.1177/002215540305100411

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  5 in total

Review 1.  New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.

Authors:  Nashmil Emami; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2007-09-15       Impact factor: 6.603

2.  The kallikrein-related peptidase 13 (KLK13) gene is substantially up-regulated after exposure of gastric cancer cells to antineoplastic agents.

Authors:  Dimitra Florou; Konstantinos Mavridis; Andreas Scorilas
Journal:  Tumour Biol       Date:  2012-09-05

3.  Cervical mucus proteome in endometriosis.

Authors:  Giuseppe Grande; Federica Vincenzoni; Domenico Milardi; Giuseppina Pompa; Domenico Ricciardi; Erika Fruscella; Francesca Mancini; Alfredo Pontecorvi; Massimo Castagnola; Riccardo Marana
Journal:  Clin Proteomics       Date:  2017-02-02       Impact factor: 3.988

4.  KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.

Authors:  N M A White; M Mathews; G M Yousef; A Prizada; C Popadiuk; J J E Doré
Journal:  Br J Cancer       Date:  2009-10-06       Impact factor: 7.640

5.  Expression of Human Kallikreins 4, 8, 10, 11 and 13 in Pleomorphic Adenomas and Mucoepidermoid Carcinomas.

Authors:  Maryam Alsadat Hashemipour; Fatemeh Sadat Fatah; Mohammad Javad Ashraf; Mehrnaz Tahmasebi
Journal:  Iran J Pathol       Date:  2016
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.